DCA
ABBV icon

DSG Capital Advisors’s AbbVie ABBV Stock Holding History

DSG Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.25M Sell
21,460
-20,849
-49% -$4.49M 0.75% 32
2026
Q1 		$9.2M Sell
42,309
-2,998
-7% -$665K 1.47% 23
2025
Q4 		$9.82M Buy
45,307
+5,090
+13% +$1.16M 1.5% 21
2025
Q3 		$9.31M Buy
40,217
+22,700
+130% +$4.62M 1.48% 22
2025
Q2 		$3.25M Sell
17,517
-294
-2% -$54.6K 0.58% 40
2025
Q1 		$3.73M Sell
17,811
-270
-1% -$52.5K 0.75% 36
2024
Q4 		$3.21M Buy
+18,081
New +$3.32M 0.58% 44

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DSG Capital Advisors's ABBV Position: Q2 2026 in Review

DSG Capital Advisors reduced its AbbVie (ABBV) stake by 49% in Q2 2026, selling an estimated $4.49M and leaving 21,460 shares worth $5.25M. The position accounts for 0.75% of the portfolio, ranked #32.

DSG Capital Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.82M in Q4 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • DSG Capital Advisors held 21,460 shares of AbbVie worth $5.25M as of Q2 2026.
  • DSG Capital Advisors sold 20,849 AbbVie shares in Q2 2026, an estimated $4.49M.
  • AbbVie made up 0.75% of DSG Capital Advisors's portfolio in Q2 2026, its #32 holding.
  • DSG Capital Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • DSG Capital Advisors's AbbVie position peaked at $9.82M in Q4 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on DSG Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.